Eribulin in Patients with Liposarcoma and Leiomyosarcoma: A Retrospective Single-Center Experience.

Oskar Steinbrecher,Thomas Brodowicz,Markus Raderer,Anke Scharrer, Johannes Fabsits,Wolfgang Lamm

Oncology（2023）

引用 0|浏览5

暂无评分

摘要

The activity and tolerability of eribulin in LPS as in well in LMS patients in the routine clinical setting is comparable to outcomes reported in published phase 3 trials.

查看译文

关键词

Eribulin,Leiomyosarcoma,Liposarcoma,Soft tissue sarcoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要